1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

$Thumbnail for Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma$

ABCL - 869

Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma

Francisco Hernandez

Poster Presenter: Francisco Hernandez

MM - 870

Isolated CNS Relapse Despite Systemic CR Following Extramedullary Disease in Primary Plasma Cell Leukemia

Sabaa Saad-Omer

Poster Presenter: Sabaa Saad-Omer

CT - 871

Frailty as a Predictor of 30-Day Readmission in CAR-T Therapy Recipients

Danielle Thor

Poster Presenter: Danielle Thor

Thumbnail for Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

AML - 872

Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

Jacob Herstein

Poster Presenter: Jacob Herstein

Thumbnail for Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

MPN - 875

Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

Jorge Sanchez Orbe

Poster Presenter: Jorge Sanchez Orbe

Thumbnail for Rising Fall- and Fracture-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 2018-2024: National Trends, Fracture-Site Burden, and Disparities

MM - 878

Rising Fall- and Fracture-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 2018-2024: National Trends, Fracture-Site Burden, and Disparities

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

Thumbnail for Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

CLL - 880

Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

Chantal Saberian

Poster Presenter: Chantal Saberian

$Thumbnail for Real-World Safety Profile of Ciltacabtagene Autoleucel in Triple-Class Refractory Multiple Myeloma: A TriNetX Analysis.$

MM - 881

Real-World Safety Profile of Ciltacabtagene Autoleucel in Triple-Class Refractory Multiple Myeloma: A TriNetX Analysis.

Hira Cheema

Poster Presenter: Hira Cheema

Thumbnail for Racial and Demographic Predictors of Time to Treatment Initiation and Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) :A Retrospective Cohort Study

ABCL - 885

Racial and Demographic Predictors of Time to Treatment Initiation and Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) :A Retrospective Cohort Study

Aneeta Channar

Poster Presenter: Aneeta Channar